We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Five-Minute Kit-on-a-Lid Assay Detects Asthma from Whole Blood

By LabMedica International staff writers
Posted on 21 Apr 2014
Print article
A team of bioengineers has developed a simple, hand-held device that enables diagnosis of asthma from a single drop of blood.

The "kit-on-a-lid-assay (KOALA)" microfluidic technology used to perform the test is the brain child of investigators at the University of Wisconsin (Madison, USA). KOALA capitalizes on differences in neutrophil function to discriminate asthma from allergic rhinitis. Neutrophils are inflammatory immune system cells that have been implicated in the pathogenesis of asthma.

The handheld KOALA device sorts neutrophils from whole blood within five minutes due to a gradient of chemoattractant that is generated in the device's microchannels when a lid with chemoattractant is placed onto the base of the device.

KOALA technology was used in a clinical setting to assay 34 asthmatic (n=23) and nonasthmatic, allergic rhinitis (n=11) patients to establish domains for asthma diagnosis based on neutrophil chemotaxis. The investigators determined that neutrophils from asthmatic patients migrated significantly more slowly toward the chemoattractant compared with nonasthmatic patients.

“What we have done in this paper is presented data that neutrophil cell function in some cases can predict — and in this case actually predicted and measured — whether someone is asthmatic or not,” said senior author Dr. David Beebe, professor of biomedical engineering at the University of Wisconsin. “This is one of the first studies to show that this process could actually work in a cheap, easy, and practical way.”

“The KOALA platform represents the next-generation biomedical research kit,” said Dr. Beebe. “Instead of getting a box of media and staining solution and having to do a lot of manual manipulation, you would get the base for the fluid sample, the prepackaged KOALA lids, and to do any testing, just place a lid (or series of lids) on the base.”

The study describing the use of KOALA was published in the April 7, 2014, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

University of Wisconsin


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Molecular Diagnostics

view channel
Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

Renal cell carcinomas (RCCs) are notably diverse, encompassing over 20 distinct subtypes and generally categorized into clear cell and non-clear cell types; around 20% of all RCCs fall into the non-clear... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.